Form 4: Catheter Precision CFO Acquires 500,000 Options
SEC Form 4 Filing
Philip J. Anderson, CFO of Catheter Precision, Inc., reports the acquisition of 500,000 options in the company.
Summary
- Philip J. Anderson, the Chief Financial Officer of Catheter Precision, Inc. (VTAK), filed a Form 4 on January 8, 2025, reporting a transaction.
- On January 6, 2025, Anderson acquired 500,000 options to buy common stock at an exercise price of $0.53.
- These options vest monthly over a three-year period, starting February 6, 2025, and expire on January 6, 2035.
- Following this transaction, Anderson directly owns 500,000 derivative securities (options).
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives.
Stakeholder Impact
- The transaction could be of interest to shareholders as it provides insight into management's view of the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 01/06/2025 | Date of options transaction |
| 02/06/2025 | Options vest monthly beginning |
| 01/08/2025 | Date of Form 4 filing |
| 01/06/2035 | Options Expiration Date |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.